-
Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.
J Virol. 2000 Mar;74(6):2740-51
PMID: 10684290
-
Differential expression of natural killer cell markers: human versus baboon.
Transplantation. 1996 Nov 15;62(9):1319-24
PMID: 8932279
-
Evaluation of cytotoxic T-lymphocyte responses in human and nonhuman primate subjects infected with human immunodeficiency virus type 1 or simian/human immunodeficiency virus.
J Virol. 2001 Jan;75(1):73-82
PMID: 11119575
-
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
Science. 2001 Apr 6;292(5514):69-74
PMID: 11393868
-
Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development.
Immunol Rev. 2001 Oct;183:127-40
PMID: 11782253
-
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
Nature. 2002 Jan 17;415(6869):331-5
PMID: 11797011
-
Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with human immunodeficiency virus gag DNA vaccines.
J Virol. 2002 Oct;76(19):10038-43
PMID: 12208982
-
Overcoming immunity to a viral vaccine by DNA priming before vector boosting.
J Virol. 2003 Jan;77(1):799-803
PMID: 12477888
-
Equivalent immunogenicity of the highly attenuated poxvirus-based ALVAC-SIV and NYVAC-SIV vaccine candidates in SIVmac251-infected macaques.
Virology. 2002 Dec 5;304(1):125-34
PMID: 12490410
-
Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene.
J Virol. 2003 Jun;77(11):6305-13
PMID: 12743287
-
Synthetic oligonucleotide probes deduced from amino acid sequence data. Theoretical and practical considerations.
J Mol Biol. 1985 May 5;183(1):1-12
PMID: 4009718
-
Effect of dose and immunization schedule on immune response of baboons to recombinant glycoprotein 120 of HIV-1.
J Infect Dis. 1989 Dec;160(6):960-9
PMID: 2555423
-
Antibodies are produced to the variable regions of the external envelope glycoprotein of human immunodeficiency virus type 1 in chimpanzees infected with the virus and baboons immunized with a candidate recombinant vaccine.
J Gen Virol. 1992 May;73 ( Pt 5):1099-106
PMID: 1375277
-
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
J Virol. 1994 Jul;68(7):4650-5
PMID: 8207839
-
Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primates.
J Virol. 1994 Aug;68(8):5036-44
PMID: 8035504
-
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
J Virol. 1994 Sep;68(9):6103-10
PMID: 8057491
-
An AIDS-like condition induced in baboons by HIV-2.
Science. 1994 Oct 28;266(5185):642-6
PMID: 7939718
-
Infection of baboons with simian/human immunodeficiency viruses.
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 15;9(5):429-41
PMID: 7627620
-
Applications of pox virus vectors to vaccination: an update.
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11349-53
PMID: 8876138
-
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.
Science. 1997 Nov 21;278(5342):1447-50
PMID: 9367954
-
Infection of baboons with a simian immunodeficiency virus/HIV-1 chimeric virus constructed with an HIV-1 Thai subtype E envelope.
AIDS. 1998 May 28;12(8):849-57
PMID: 9631137
-
Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells.
Curr Opin Immunol. 1998 Aug;10(4):444-9
PMID: 9722921
-
Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression.
Cytometry. 1998 Oct 15;34(5):207-15
PMID: 9822306
-
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
Science. 1999 Feb 5;283(5403):857-60
PMID: 9933172
-
Development of a single-shot subunit vaccine for HIV-1. 5. programmable in vivo autoboost and long lasting neutralizing response.
J Pharm Sci. 1998 Dec;87(12):1489-95
PMID: 10189254
-
Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors.
Immunol Lett. 1999 Mar;66(1-3):9-14
PMID: 10203028
-
Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.
J Virol. 1999 Sep;73(9):7524-32
PMID: 10438842
-
Protection by live, attenuated simian immunodeficiency virus against heterologous challenge.
J Virol. 1999 Oct;73(10):8356-63
PMID: 10482586
-
Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay.
J Virol. 2000 Sep;74(18):8541-9
PMID: 10954555